c-Met-IN-26

• UNSPSC Description:

  c-Met-IN-26 (compound 1-170) is a potent inhibitor of c-Met, with the IC50 of 1.6 nM. c-Met-IN-26 palys an important role in cancer research[1].

• Target Antigen:

  c-Met/HGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/c-met-in-26.html

• Smiles:

  CN(N=C1)C=C1C2=NC(N(C(C)C3=C(F)C4=C(N=CC(C5=CN(C)N=C5)=C4)C=C3F)C=N6)=C6N=C2

• Molecular Weight:

  471.46

• References & Citations:

  [1]Shanghai Pharmaceuticals Holding Co., Ltd. Quinoline-series compound, its preparation method, and pharmaceutical application. China, CN104109166 A 2014-10-22.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1635406-97-1